Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FV8XF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,493
Award facts
- Contract value 100% obligated
- $4,493.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,493.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on January 29, 2026, with an ultimate completion date of February 20, 2026. This delivery order is a child contract issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was not set aside and was competitively awarded, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered.
AmerisourceBergen Drug Corp serves as a critical vendor in the federal medical supply chain, particularly supporting military and veteran healthcare systems through the DLA's pharmaceutical distribution network. The Varivax vaccine delivery represents part of the company's comprehensive portfolio of medical product deliveries spanning brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV8XF?
SPE2DR26FV8XF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV8XF worth?
The government has obligated $4,493 on SPE2DR26FV8XF.
Is contract SPE2DR26FV8XF an order under another contract?
Yes. SPE2DR26FV8XF is a delivery order under SPE2DR25D7056, an indefinite delivery contract.
Was contract SPE2DR26FV8XF competed?
The extent of competition for SPE2DR26FV8XF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award